Evaluating AI for thyroid nodule diagnosis

• by Julia Cipriano, MS, CMPP

• March 18, 2026

GLP-1 Drugs Linked to GI Effects, Uncertain Signals

Umbrella review evaluates over 1,700 trials to assess noncardiometabolic outcomes beyond weight and glycemic effects.

• by Kathryn Wighton

• April 16, 2026

• 3 min

Behavior of serum thyroglobulin in relation to thyroid function under low-thyrotropin conditions in general practice

• by Yosuke Sazumi, Yoshiaki Soejima, Yuki Otsuka, Yasuhiro Nakano, Koichiro Yamamoto, Atsuhito Suyama, Ryosuke Takase, Kohei Oguni, Miho Yasuda, Masanori Furukawa, Fumio Otsuka

• May 15, 2026

Dose–response relationships of normal blood lipid levels in metabolic and endocrine diseases: mechanistic similarities, differences, and functional insights

• by Xinyue Hu, Xiaofang Yang, Zhou Zhu, Zhihong Yang, Pengyu Wang, Min Wu, Ning Zhang

• April 16, 2026